Catalina Ana Rosselló Castillo

Catalina Ana Rosselló Castillo has a diverse work experience spanning various roles and companies. Catalina Ana began their career in 2003 as a Project Researcher and Graduate Fellow at Universitat de les Illes Balears, where they focused on gene regulation and obesity prevention. Catalina Ana then moved on to Centro Nacional de Biotecnología CNB-CSIC, where they worked as a Graduate Fellow, conducting research in developmental biology using genetic engineering techniques.

After completing their graduate fellowship, Rosselló Castillo joined IFOM-IEO Campus as a Research Stay, where they made significant contributions to chromatin immunoprecipitation and gene control studies. Catalina Ana then gained extensive experience as a Senior Technician at Fundación centro nacional de investigación cardiovascular CNIC Carlos III, studying homeobox transcription factors and the generation of embryonic hematopoietic stem cells.

In 2011, Rosselló Castillo became a Postdoctoral Researcher at Lund University, investigating nuclear gamma-tubulin-driven oncogenesis and exploring novel targets for inhibiting cell division. Catalina Ana made significant discoveries regarding gamma-tubulin's role in nuclear function.

In 2014, Rosselló Castillo returned to Universitat de les Illes Balears as an Intra European Fellow, conducting molecular characterization of Minerval and its potential for treating gliomas and solid tumors. Catalina Ana then held various roles in the university, including Associate Lec and Associate Lecturer.

In 2016, Rosselló Castillo joined Laminar Pharma as the Head of Department Chemistry Manufacturing Controls. Catalina Ana led a team, projected drug substance and product needs, managed vendors, supported regulatory filings, and oversaw supply chain and logistics for clinical studies.

In 2018, they became the Director of Clinical Research and Development at Laminar Pharma, responsible for overseeing clinical programs and development.

Finally, Rosselló Castillo is set to become an Associate Lecturer at Universitat de les Illes Balears in 2022, further contributing to academia.

Throughout their career, Rosselló Castillo has demonstrated expertise in drug development, molecular biology, oncology research, and gene regulation.

Catalina Ana Rosselló Castillo's education history is as follows:

From 1997 to 2003, they attended the Universitat de les Illes Balears, where they obtained a Licentiate degree in Biology, with a focus on general biology in 2002 and biochemistry in 2003.

Following this, from 2004 to 2010, they pursued a Doctor of Philosophy (Ph.D.) at the Universidad Autónoma de Madrid, specializing in molecular biology.

Lastly, in 2022 and 2023, they enrolled in CESIF, obtaining a Master's degree in Industrial Pharmacy and Drug Registration through an online program.